(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -61.69%-860.56K | -532.23K |
Payments to suppliers for goods and services | -61.69%-860.56K | ---532.23K |
Direct interest received | --146K | ---- |
Operating cash flow | -34.26%-714.56K | ---532.23K |
Investing cash flow | ||
Cash flow from continuing investing activities | -221.48%-1.53M | -475.2K |
Capital expenditure reported | -194.37%-1.38M | ---469.36K |
Net PPE purchase and sale | 57.00%-2.51K | ---5.83K |
Net investment purchase and sale | ---143.47K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -221.48%-1.53M | ---475.2K |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.37%-31.12K | 8.37M |
Net common stock issuance | ---- | --7.78M |
Net other financing activities | -105.23%-31.12K | --594.49K |
Cash from discontinued financing activities | ||
Financing cash flow | -100.37%-31.12K | --8.37M |
Net cash flow | ||
Beginning cash position | --7.36M | ---- |
Current changes in cash | -130.87%-2.27M | --7.36M |
End cash Position | -30.87%5.09M | --7.36M |
Free cash from | -110.31%-2.12M | ---1.01M |
Accounting Standards | US-GAAP | US-GAAP |
No Data